D. J. Hijnen
www.mendeley.com
0000-0003-3379-3425
Erasmus MC
11 papers found
Refreshing results…
Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry
EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab
Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study
Genetic Susceptibility to Dry Skin in a General Middle-Aged to Elderly Population: A GWAS
Immunohistochemical Characterization of the IL-13:IL-4 Receptor α Axis in the Skin of Adult Patients with Moderate to Severe Atopic Dermatitis and Healthy Controls
EASI p‐EASI: predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity
EASI p‐ EASI : Predicting disease severity in atopic dermatitis patients treated with cyclosporin A
Serum biomarker profiles suggest that atopic dermatitis is a systemic disease
EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients
Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity
Missing publications? Search for publications with a matching author name.